4//SEC Filing
Valeant Pharmaceuticals International, Inc. 4
Accession 0000885590-16-000111
$BHCCIK 0000885590operating
Filed
May 15, 8:00 PM ET
Accepted
May 16, 4:29 PM ET
Size
5.3 KB
Accession
0000885590-16-000111
Insider Transaction Report
Form 4
Rosiello Robert L.
EVP, Chief Financial Officer
Transactions
- Award
Common Stock, no par value
2016-05-12+84,975→ 534,525 total
Footnotes (2)
- [F1]Represents Restricted Share Units("RSUs") representing a contingent right to receive one share of common stock, no par value, of Valeant Pharmaceuticals International, Inc.
- [F2]One-third (1/3) of the RSUs will vest six months from the date of grant, one-third (1/3) of the RSUs will vest twelve months from the date of grant and one-third (1/3) of the RSUs will vest eighteen months from the date of grant, subject to continued employment through each vesting date.
Documents
Issuer
Valeant Pharmaceuticals International, Inc.
CIK 0000885590
Entity typeoperating
IncorporatedNJ
Related Parties
1- filerCIK 0000885590
Filing Metadata
- Form type
- 4
- Filed
- May 15, 8:00 PM ET
- Accepted
- May 16, 4:29 PM ET
- Size
- 5.3 KB